These are the suburbs where the Aussie property dream is still rising
“Dwell I but in the suburbs of your good pleasure?” Friends of the show will recall that at the beginning of this, the 11th [more…]
Brokers on Monday: Clinuvel finds friends; ANZ’s unimpressive outlook
We check in with some of the week’s notable broker moves. This week we focus on Clinuvel Pharmaceuticals and the ANZ Bank… Clinuvel Pharmaceuticals [more…]
Q+A: Perseus Mining’s Jeff Quartermaine on why the $2.5bn African gold miner aims to be a ‘fast tortoise’
Perseus Mining is down 16% YTD despite rolling out its best ever production year of more than 530,000oz in FY23 Now a regular dividend payer, [more…]
Hot Money Monday: How Newton’s first law and these 3 momentum signals could turn trends to profits
The concept of momentum is based on Newton’s first law of motion – which states that an object in motion will continue to stay in [more…]
Traders’ Diary: The wolves are at the door, but the bulls are in the bathroom
THE WEEK THAT WAS Around the wide world share markets were largely higher by the end of last week, engorged on the tasty news [more…]
Who came close to nabbing a spot on Argonaut’s top undeveloped projects list?
Argonaut has delivered its 2023 list of best undeveloped mining projects on the ASX But which 12 exciting projects sat just outside its criteria Lithium, [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to Monday, 20 November – a date on the calendar that holds a special place in the lycra-clad hearts of [more…]
STATE vs STATE, RATE vs RATE: What 13 bumps to the cash rate does to Australian
It’s not easy being green and gold when your local central bank can dish out by the bakers’ dozens 25 casual basis point cash rate [more…]
Optiscan’s platform could address global pathologist shortage
Optiscan’s platform could help with shortage of pathologists in Australia and globally Platform particularly useful in diagnosing malignant tumours and pre-cancerous lesions in surgery Optiscan [more…]
CRITERION: It’s a pool party as private equity splashes cash on small cap financial advisors
Investors looking for takeover action in 2024 should look no further than the hitherto sleepy small-cap financial advisory sector, where the pace of consolidation is [more…]
